These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A standardized parenteral nutrition solution: prescribing, use, processing, and material cost implications.
    Author: Petros WP, Shank WA.
    Journal: Hosp Pharm; 1986 Jul; 21(7):648-9, 654-6. PubMed ID: 10311603.
    Abstract:
    The influence of a standardized parenteral nutrition solution (TPN) on prescribing patterns, use, preparation time, and material costs was studied. The percentage of patients receiving the standardized TPN was derived from a 5-month utilization study. A retrospective chart review evaluated 50 patients receiving nonstandardized TPN (Group I) and 48 patients receiving standardized TPN (Group II). A stopwatch motion study of the IV admixture service evaluated processing and compounding time. Material cost savings resulting from standardized TPN use was evaluated. Order changes in Group I patients occurred on the average of once every 3.4 days. Alterations in electrolyte composition accounted for 73% of order changes. Prescribing error frequency was 9.3% in Group I patients. After implementation of the standardized TPN solution, 73% of patients receiving TPN during the study period were prescribed the standardized solution. Prescribing error frequency was 0% in Group II patients. The standardized TPN solution decreased processing and compounding time by 55% (p less than 0.01) and decreased material cost by 19%. Although some patients require individualized solution formulae, a majority of adult patients tolerate standardized TPN without adverse metabolic complications. A standardized TPN solution can decrease processing and compounding time, favorably affect prescribing patterns, and lower solution costs without adversely affecting patient safety.
    [Abstract] [Full Text] [Related] [New Search]